Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > General comments, leading to Monday am N.R. Etc
View:
Post by canadafan on Aug 12, 2023 12:19pm

General comments, leading to Monday am N.R. Etc

First a shout out to those who know me on a more personal level.
The fireside chat, as I said was cryptic at best.
That I find very interesting. Not discouraging.....I'll explain at the end.
Question , why?
Consider the background of the talk.
The 2 being interviewed. Extremely educated. Dr. Matt , mutiple peer reviewed publications.
My point, they go into these things knowing exactly what to expect & how to interpret.
The questions were pre- arranged. 
Only a fool would be caught off guard with a random " out there" question.
It's called preparation. Again, in their background & training. They are not capable of getting on a mic, without knowing beginning & ending of where things are going to go.
So, why the vague answers & muddy explanations around MBc & panc phase 3 " partners"?
1. If things were dead, or leaning that way...they would not have agreed to the fireside chat.
2. The most positive point they raised, was that the recent $15million was brought in by a single medical affiliation.  " most of it"
3. Matt also said, that was the first time in their history that type of buy , has happened.
Again imho, intersting why a Canadian investor would become close to but just under a 10% holder of the Canadian float.
Back to why encouraging, not discouraging. 

They did say, as they have for many months now. When asked about B.D. Plans.
" we continue to engage with the likes of Pfizer , Roche & others" ..paraphrase, something like that.
Straight up! 

When people give you inconclusive information, they are intentionally not revealing something.
Why would an investor take on a $10-$15 usd , investment in something failing? 
They would not!
Matt et. al. Know exactly who bought those shares & why.
I'm beyond seeing a linear path. 
No doubt lots going on.
Regarding S.P. 

I saw some numbers published, substantially higher shorting the last 30 days.
Monday, hopefully shines some light on the questions. The retail segment hates unknowns & doubt.
Last point.
99.9% of the time, I do not get into direct naming of others who post.
This site in particular has a reasonable exchange of ideas & thoughts about oncolytics biotec, the virus Pelareorep & the progress of many trials. Up to & including rationals of various B.D. Deals.
That is the point if these chat rooms. Additionally, I always refer anyone with doubts to go to company site & read presentations.
or , go back & listen to recordings of interviews.
We do have one very persistent troll. Who BTW is using a stolen name. Buck Henry was the creator of 1960s Get Smart. Long dead.
A quick search of his posts , show time & time again: personal attacks, open negative comments, with zero substance. 
Reminds me of high school washroom wall writings.
The technical word is Ad Hominem attacks.
Just like my curiosity after the recent fireside chat. Why would anyone do that?
motive?
Like I said, lots of shorting lately.
Regardless. My advice for those who can, tune in in Monday.

Comment by 13X2413 on Aug 12, 2023 1:03pm
Finally, a sensible level headed post. Good work, hope to hear more from you. 
Comment by Buckhenry on Aug 12, 2023 4:06pm
Canuckfan and unnoteable  continue to write worthless desertations ie.. opinions. No one knows if and when this stock will pay off. So quit talking like your sitting at the head of the boardroom. I'm just holding out for the day I don't have to read anymore worthless posts on here.  I'm sure you folks don't like mine but it's still a free country so get over it or ...more  
Comment by canadafan on Aug 13, 2023 1:29pm
If you want to not see worthless posts. simple stop posting.
Comment by canadafan on Aug 13, 2023 1:32pm
My last post directed to our very persistent troll mr Buck henry all others please carry on. we have a reasonable board here. again. buvk heny has yet to say anything of substance , regarding oncolytics biotech or Pela or any opportunities. he just throws out silly, grade school comments.
Comment by westcoast1000 on Aug 12, 2023 6:57pm
Reply to Canadafan, Thanks for your thoughts. The questions were undoubtedly prepared by the ONCY staff and the responses scripted. I did not find it enlightening at all except in two crucial points: -the discussion of the emergence of Eruhutu (An ADC) as the new SOC for first line mBC in the groups we were targetting.  -the fact that both the company and their BP partners are ...more  
Comment by fox7mf on Aug 12, 2023 7:16pm
No one can argue with your assessment WC. Enherto developments were definitely gutting. ASCO provided little excitement. PanCan was great, but we were led to believe a lot more was coming in 90 days (closer to 40 now.) Buyout and partnerships appear to be far off if they happen at all. Disconcerting ramblings about mBC.Perhaps they expect CRC to replace mBC as our 2nd ph3?  Oncy needs to ...more  
Comment by westcoast1000 on Aug 12, 2023 7:25pm
Fox, The audience for this talk was the Cannacord investors, who are not who we really need anyway. Monday is a more formal talk. But I am not holding out much hope. Again, sell the freaking company already! Uncartainties (like competitors being successful) can get you and hurt you in this world.  As an aside, I have only been confident in the company over the last two years because of ...more  
Comment by westcoast1000 on Aug 12, 2023 7:32pm
Following on, One possibility is that BP really discounts the uncertainty of going from a P2 to a finished P3 and approval. But the purchases of what seemed to be innovative companies with p 1 clinical results belies that. I do not think we have poor management. I certainly did feel that back in the days of the former guy  Somewhere there is a hesitation to do a deal with what we have now ...more  
Comment by itntdf on Aug 12, 2023 8:51pm
at the risk of beating a dead horse, the 90 day mention was to finalize an agreement between oncy and pancan.  the nr clearly stated the p3 trial would not start until early 2024. any bp waiting for results from pancan would not be jumping in at this time to make a bid for the company. agree that matt put too much frosting on the cake and this wait is water torture, but maybe the recent ...more  
Comment by inthno on Aug 12, 2023 8:48pm
I did notice that Matt never said we are still continuing on with our lead program in mbc. I too believe it is on the backburner with panc leading the way. The hope is that AN will still take mbc and run with it but not in their major pipeline at the moment so no guarantee of that either. So yes, they said that they will write the protocols for the phase 3 for mbc but does not mean that it will ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse